Sepsis is a systemic infection that enhances host vulnerability to secondary infections normally controlled by T cells. Using CLP sepsis model, we observed that sepsis induces apoptosis of circulating memory CD8 T-cells (T CIRCM ) and diminishes their effector functions, leading to impaired CD8 T-cell mediated protection to systemic pathogen re-infection. In the context of localized re-infections, tissue resident memory CD8 T-cells (T RM ) provide robust protection in a variety of infectious models. T RM rapidly 'sense' infection in non-lymphoid tissues and 'alarm' the host by enhancing immune cell recruitment to the site of the infection to accelerate pathogen clearance. Here, we show that compared to pathogen-specific T CIRCM , sepsis does not invoke significant numerical decline of Vaccinia virus induced skin-T RM keeping their effector functions (e.g., Ag-dependent IFN-γ production) intact. IFN-γ-mediated recruitment of immune cells to the site of localized infection was, however, reduced in CLP hosts despite T RM maintaining their 'sensing and alarming' functions. The capacity of memory CD8 T-cells in the septic environment to respond to inflammatory cues and arrive to the site of secondary infection/antigen exposure remained normal suggesting T-cellextrinsic factors contributed to the observed lesion. Mechanistically, we showed that IFN-γ produced rapidly during sepsis-induced cytokine storm leads to reduced IFN-γR1 expression on vascular endothelium. As a consequence, decreased expression of adhesion molecules and/or chemokines (VCAM1 and CXCL9) on skin endothelial cells in response to T RMderived IFN-γ was observed, leading to sub-optimal bystander-recruitment of effector cells and increased susceptibility to pathogen re-encounter. Importantly, as visualized by intravital 2-photon microscopy, exogenous administration of CXCL9/10 was sufficient to correct sepsis-induced impairments in recruitment of effector cells at the localized site of T RM antigen recognition. Thus, sepsis has the capacity to alter skin T RM anamnestic responses PLOS Pathogens | https://doi
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Introduction
Sepsis is the result of a systemic infection that elicits a cytokine storm characterized by host tissue damage following production of pro-and anti-inflammatory cytokines. Globally, there are 31.5 million cases and 5.3 million deaths from sepsis annually. Interestingly, most mortality occurs after resolution of the relatively brief acute phase of sepsis and is associated with enhanced susceptibility to secondary infections usually eradicated by a normal functioning immune system [1, 2, 3, 4, 5] . Observations of T cell apoptosis in septic patients originally provided insight to a potential underlying lesion in T cell-mediated immunity during the state of immunoparalysis after sepsis induction [6, 7] .
Using the cecal ligation and puncture (CLP) experimental model of sepsis induction we previously determined that sepsis reduces the number of naïve CD4 and CD8 T cells and impairs primary T cell responses to a variety of acute (lymphocytic choriomeningitis virus (LCMV) Armstrong, Listeria monocytogenes, Candida albicans) and chronic (LCMV clone-13) infections [8, 9, 10, 11] . Polymicrobial sepsis also affects infection and/or vaccine-induced memory CD8 T cell responses by inducing apoptosis of pre-formed memory CD8 T cells and impairing the Ag-dependent and-independent memory CD8 T cell functions (e.g., functional avidity and IFN-γ production upon heterologous infection, respectively) [10, 12, 13] . In addition to these T cell-intrinsic factors affected in the post-septic host, deficiencies in T cellextrinsic factors [e.g., dendritic cells (DC) capacity to provide 'signal 3' cytokines to promote optimal T cell responses], severely restrict the generation of productive T cell responses [14, 15] . These reports suggest contributing mechanisms that define the immunoparalysis phase of sepsis leading to increased susceptibility to secondary infections normally controlled by T cells.
Most (if not all) of the prior reports describing the impact of sepsis on naïve or memory T cells have focused on cells in peripheral blood and/or secondary lymphoid organs (SLO). However, vaccination or infection can generate two distinct populations of memory CD8 T cells distinguished by their unique migration capacity and transcription profiles [16] . Circulating memory CD8 T cells (T CIRCM ) circulate throughout the body in the peripheral blood and SLO searching for cognate Ag, while tissue resident memory CD8 T cells (T RM ) remain localized in previously-infected host barrier tissues (e.g. skin, lung, gut) commonly exploited by pathogens to mediate host entry [17] . T RM positioned in non-lymphoid tissue (NLT) survey their environment by interacting with antigen-presenting cells (APC) and rapidly facilitate Ag-dependent 'sensing' of infection and 'alarming' the host, creating a tissue-wide pathogen alert to rapidly orchestrate anamnestic responses [18, 19, 20, 21] . Mechanistically, upon Ag recognition, T RM -derived IFN-γ enhances expression of chemokines and adhesion molecules on vascular endothelium to promote bystander recruitment of circulating Ag-experienced T and B cells to the infected tissue to participate in rapid pathogen clearance. Thus, a critical interplay exists between T RM and T CIRCM in providing optimal protection upon pathogen re-encounter [18, 19] . The contribution of T RM in mediating protection against pathogen re-challenge has been demonstrated in a variety of tissues including the skin [20, 22, 23, 24] , female reproductive tract [18, 25] , and lung [26, 27] . Despite the observed and now appreciated importance of T RM in controlling localized infections, the impact of sepsis on the quantity (number) and quality (capacity to perform Ag-dependent 'sensing' and 'alarming' function) of CD8 T RM has not been rigorously defined.
To address this knowledge gap, CD8 T CIRCM and skin, lung, and/or small intestine T RM were generated in mice through vaccinia virus (VacV; skin), LCMV (lung and small intestine), or influenza (lung) infections and analyzed after CLP or sham surgery. Our data show sepsis reduced the number and Ag-dependent function (production of IFN-γ) of T CIRCM to a greater extent than T RM of the same Ag-specificity. Despite optimal 'sensing' and 'alarming' function of skin T RM , septic hosts displayed tremendous impairment in bystander T and B cell recruitment to the skin upon T RM activation, which was not solely attributed to numerical loss of these populations in the circulation after sepsis induction. Instead, the vascular endothelium of septic hosts had reduced IFN-γ receptor expression that correlated with reduced expression of IFN-γ inducible proteins on vascular endothelium after skin T RM activation. Lastly, the observed impairments in the T RM -mediated anamnestic response greatly reduced the protective capacity of skin T RM to homologous infection in immune mice. In total, our data show the sepsis-induced impairments in skin T RM -mediated protection against secondary infection was driven by T RM -extrinsic factors. Therefore, sepsis modulates host response to pathogen reinfection either by directly influencing memory CD8 T cell populations or by preventing other cell types to properly respond to pathogen-induced alarming signals delivered by resident memory CD8 T cells in barrier tissues.
Results
Sepsis reduces number of T CIRCM to a greater degree than T RM of the same Ag-specificity to systemic bacterial and viral infections [12] . CD8 T CIRCM are only part of the memory CD8 T cell compartment, as CD8 T RM are now recognized to be critical in providing protection against localized infections in a variety of barrier tissues (e.g. skin and lung) [22, 24, 26] .
To generate circulatory and tissue-resident memory CD8 T cells, a low number of naïve Thy1.1 P14 cells specific for LCMV-derived GP 33 epitope were transferred into Thy1.2 C57Bl/ 6 (B6) mice followed by VacV-GP 33 infection of the left ear [30] . At a memory time point (d 30+ post infection), CD45.2 mAb was injected i.v. to distinguish T RM (CD45.2-) from T CIRCM (CD45.2+; S1A Fig) [31, 32] . VacV-GP 33 infection generated a memory P14 population in the left ear protected from CD45.2 mAb recognition and expressing CD103, a marker of skin T RM [33] . Consistent with previous data, CD8 T RM also accumulate in distal locations from the primary site of skin infection, such as the contralateral right ear, but at greatly reduced number (S1B Fig) [22, 24, 34] . In a similar experimental approach using systemic LCMV infection, skin T RM were not detected in the left ear (S1C and S1D Fig) , further supporting the premise that skin T RM formation is dependent on the route of infection and specific pathogen [35] .
With a system in place to generate T RM , we next examined the impact of sepsis on pre-existing Ag-specific skin T RM . VacV-GP 33 -immune mice underwent cecal ligation and puncture (CLP) or sham surgery and 2 days later memory P14 cells enumerated ( Fig 1A) . As expected, sepsis reduced the number of P14 T CIRCM in the blood and spleen by 5.9-and 2.9-fold, respectively. In contrast, the number of P14 T RM (gated and defined as cells not labeled with intravascular injected antibody (CD45.2 negative) and CD103+) in the skin did not change after sepsis induction (Fig 1B) . Of note, most of the T CIRCM cell death in the peripheral blood occurs during the first 48 hours after sepsis induction coinciding with duration of sepsis-induced cytokine storm (S2A- S2C Fig) . However, to formally prove that sepsis does not influence T RM with delayed kinetics compared to T CIRCM both memory CD8 T cell populations were analyzed 4 days post sepsis induction (S2D- S2F Fig) . Results clearly showed that ear T RM are still numerically intact compared to sham counterparts suggesting apoptosis of the T RM population is not delayed in this system (S2D- S2F Fig) . Together, these data suggest T CIRCM are more susceptible to the sepsis-mediated cues responsible for deletion than skin T RM of the same Agspecificity.
Inbred mouse strains facilitate tracking an Ag-specific CD8 T cell population with known stimulation history; however, inbred mice are genetically homogenous and do not necessarily capture the genetic diversity associated with a human population. To determine the impact of sepsis on the number of skin T RM in a genetically heterogeneous population, we performed sham or CLP surgery on VacV-immune outbred Swiss Webster mice (Fig 1C) . Similar to what was observed with the inbred B6 mice, sepsis significantly reduced the number of CD8 T CIRCM (distinguished using surrogate activation marker of memory CD8 T cells, CD8α lo CD11a hi ) [36, 37] in the peripheral blood and spleen but not skin CD8 T RM . (Fig 1D) . Collectively, the data in Fig 1 show that sepsis leads to significant numerical loss of CD8 T CIRCM in peripheral blood and SLO but little-to-no numerical alterations of skin T RM counterparts regardless of the genetics of the hosts examined.
Using different pathogens and routes of infection we generated T RM in other NLT (e.g. lung and small intestine) and determined the impact of sepsis on the number of T RM . To test the impact of sepsis on lung T RM , B6 mice received an adoptive transfer of naïve P14 cells followed by intranasal IAV PR8-GP 33 host, we found a significant increase in the frequency of CD45.2+ lung vasculature CD8 T cells with activated caspase-3/7 in CLP-versus sham-treated mice (S3L- S3N Fig) suggesting sepsis leads to apoptosis of circulatory memory CD8 T cells.
Lastly, we examined the impact of sepsis on the number of lung and small intestine T RM in LCMV-Armstrong infected mice. Naïve P14 cells were transferred into B6 mice before i.p. infection with LCMV-Armstrong. CLP or sham surgery was performed 30 days later, and tissues were harvested after 2 days (S4A Fig). Similar to previous models, sepsis increased the representation of lung and small intestine CD45.2-P14 cells compared to their CD45.2+ counterparts (S4B-S4D Fig) which attributed with a significant decline in the number of lung P14 T CIRCM (S4E Fig). Taken together, using three infection models (VacV, influenza, and LCMV) to generate CD8 T RM populations in multiple barrier tissues (skin, lung, and small intestine) before CLP or sham surgery, our data demonstrate sepsis greatly reduces the total number of pre-existing memory CD8 T cells. However, the observed numerical loss after sepsis is primarily occurring in the CD8 T CIRCM population leaving the tissue-embedded CD8 T RM population numerically intact.
CD8 skin T RM maintain Ag-dependent 'sensing' and 'alarming' function after sepsis induction
We previously reported that, in addition to the numerical loss of cells, sepsis also reduces the Ag-dependent function (e.g., production of effector cytokines or secondary proliferative expansion in numbers following Ag re-encounter) of surviving CD8 T CIRCM further contributing to the observed impairment in CD8 T cell-mediated immunity [12] . Upon homologous infection and recognition of cognate Ag, T RM -derived effector cytokines (e.g., IFN-γ) invoke a tissue-wide state of pathogen alert and facilitate bystander recruitment of memory B and T cells to participate in pathogen clearance [18, 19, 20] . Thus, we next determined the impact of sepsis on Ag-dependent 'sensing' and 'alarming' function of skin T RM in vivo. VacV-immunized mice received CLP or sham surgery 30 days after primary infection. Two days later, mice received in vivo GP 33 peptide stimulation and 6 hours later tissues were harvested and intracellular cytokine stain (ICS) for IFNγ performed directly ex vivo without further stimulation and/or inhibition of protein transport with Brefeldin A (Fig 2A) [34] . Importantly, in vivo intradermal peptide injection activated both T RM and T CIRCM , allowing us to determine the effect of sepsis on Ag-dependent functions of both CD8 T RM and T CIRCM in the same host. Sepsis reduced the frequency, per-cell production, and number of IFN-γ producing T CIRCM in the spleen (Fig 2B-2D) . In contrast, skin T RM in septic hosts retained their ability to sense cognate Ag and respond with IFN-γ production to the same degree as in shamtreated mice (Fig 2E-2G) . Although it is unlikely that IFN-γ production detected by memory CD8 T cells occurs in vitro during the relatively short period needed to process and stain ear/ spleen cells, it is formally possible that residual antigen (if any) can prime or facilitate IFN-γ production by memory CD8 T cells present in the cell suspension. To directly test this, CFSE-labeled 'sensor' cells (memory GP 33 T RM -derived IFN-γ induces the expression of chemokines and adhesion molecules on local vascular endothelium to promote bystander recruitment of Ag-experienced T and B cells to the site of T RM activation [18, 19] . Since sepsis had no impact on the 'sensing' and 'alarming' Ag-dependent function of skin T RM , we did not expect to see any modulation in bystander immune cell recruitment in septic hosts upon Ag/pathogen re-encounter at the local site. To test this, VacV-immune mice underwent CLP or sham surgery 30 days after primary VacV infection. The mice received CD45.2 mAb i.v. injection 2 days later to determine baseline cellularity, and cells within the ear were enumerated. Additional cohorts of mice received in vivo GP 33 peptide stimulation in the ear, followed by enumerating the recruited cells from the circulation 2 days later ( Fig 3A) [18] . Surprisingly, sepsis impaired the recruitment of circulating cells to the site of skin T RM activation resulting in a 4.7-fold reduction in ear cellularity (compared to sham-treated mice), which was attributed to 5.6-, 3.1-, and 3.9-fold decreases in number of CD8+ and B cells (CD8-/B220+) and P14 cells in the ear, respectively (Fig 3B-3E ). Next, we tested the capacity of skin T RM to recruit circulating memory B and T cells to the skin upon homologous VacV infection (Fig 3F) . Upon VacV re-challenge, CLP hosts had 3.9-, 2.4-, and 2.9-fold reductions in the number of CD8+, B cells (CD8-/B220+) and P14 cells, respectively, at the site of re-infection compared to sham counterparts (Fig 3G-3J) . Thus, despite proper number and optimal Ag-dependent 'sensing' and 'alarming' functions of skin T RM , sepsis impairs bystander recruitment of circulating T and B cells to the site of skin T RM activation.
Capacity of CD8 T CIRCM cells to follow inflammatory cues and migrate to the inflamed tissue is not influenced by sepsis
One obvious explanation for the observed impairment in bystander recruitment was the sepsis-induced numerical loss of circulating memory B and T cells, effectively limiting the number of cells that could potentially respond to inflammatory cues and travel to the site of infection. However, it is also formally possible that sepsis or the post-septic environment changes the ability of circulatory effector cells (in this case memory CD8 T cells) to respond to inflammatory cues and arrive at the place of re-infection. To directly test this, equal number of splenocytes containing memory CD8 T cells obtained from LCMV-immune P14 chimera mice 2 days after sepsis induction were CFSE labeled and transferred into congenic Vacv-GP 33 -immune P14 chimera mice (Fig 4A) . Ears of all recipient mice were treated with GP 33 peptide to trigger sensing and alarming function of T RM and the number of CFSE-labeled CD8+ or P14 cells enumerated in the ears 2 days later. Interestingly, spending 2 days in the CLP environment does not change the ability of memory CD8 T cells to migrate into the normal skin (Fig 4A-4C ) suggesting that sepsis does not change capacity of remaining memory CD8 T cells to follow inflammatory cues in vivo.
To further boost this observation and provide mechanistic insight into the notion that T cells exposed to septic environment retain ability to respond to inflammation, T CIRCM were obtained from sham or CLP LCMV-immune hosts 2 days after surgery and their migratory capacity to CXCR3 ligands (CXCL9 and 10) [38, 39] was analyzed directly ex vivo in a transwell system ( Fig 4D) . As suggested in S2 Fig where the phenotype of cells obtained from sham or CLP hosts was compared, sepsis also did not change the expression of CXCR3 on P14 T CIRCM cells used in this assay (Fig 4E) . No discernable differences were observed in the migratory capacity of memory P14 or bulk Ag-experienced CD8 T cells obtained from sham or CLP hosts in response to CXCL9 or CXCL10 stimuli (Fig 4F and 4G) . Consistent with published data [40, 41] , all the migrated P14 cells lost the expression of CXCR3 strongly suggesting CXCL9/10-dependent migration (Fig 4H) . Taken together, the data shown here suggest sepsis does not influence memory CD8 T cell capacity to recognize inflammatory cues and relocate to the site of inflammation. To determine the extent to which the lesion in bystander recruitment was due to sepsisinduced numerical loss of circulating cells or if T cell-extrinsic factor(s) contributed to the defect observed, VacV-immune mice underwent CLP or sham surgery and cells within left ear were enumerated 2 days later. A companion cohort of mice received equal numbers of CFSElabeled splenocytes from LCMV-immune donor mice, followed by in vivo GP 33 peptide injection in the left ear to activate skin T RM and induce the recruitment of bystander host (CFSE-) or transferred (CFSE+) cells (Fig 5A) . Due to the lymphopenic environment of septic hosts, the CD8+CFSE+ donor cells comprised a significantly higher frequency of the cells within the spleen compared to sham controls ( Fig 5B and 5C ) but a similar number of these cells were present in the spleens of both groups of mice ( Fig 5D) .
Activation of skin T RM will lead to an increase in the thickness of the ear pinna, indicating a localized anamnestic response [34] . We noted a significant reduction in ear thickness in the CLP-treated mice following skin T RM activation compared to sham controls, providing further evidence that sepsis impairs the recruitment of bystander cells to the site of skin T RM activation ( Fig 5E) . In addition to assessing the general response at the level of ear thickness, this experimental design also facilitated the specific quantitation of host (CFSE-)-and donor (CFSE +)-derived bystander cell recruitment of cells in the same animal ( Fig 5F) . Similar to Fig 3, CLP-treated mice showed a significant reduction in the recruitment of total (5.5-fold less), CD8+ (10-fold less), and B cells (CD8-/B220+; 4.9-fold less) cells to the site of skin T RM activation (Fig 5G-5I) . Importantly, donor CFSE-labeled CD8+ and B cells (CD8-/B220+) cells were also significantly reduced in number (11-and 23-fold less, respectively) at the site of skin T RM activation (Fig 5J and 5K) . To exclude the possibility that post-septic environment influences the capacity of transferred memory CD8 T cells to respond to inflammation and/or cognate antigen stimulation recipient mice underwent sham or CLP surgery and 2 days later received splenocytes from LCMV-immune P14 chimera hosts (S7A Fig). Spleens were harvested after an additional 2 days and the memory P14 cells analyzed. Data presented in S7B-S7G Fig clearly showed that Ag-independent (bystander IFN-γ production in response to combination of inflammatory cytokines) and Ag-dependent (IFN-γ, TNF and IL-2 production in response to cognate antigen) responses of memory P14 CD8 T cells are normal, if not enhanced, even if those cells were exposed to post-septic environment. Thus, these data suggest the sepsisinduced reduction in recruitment of circulating effector cells into sites of T RM activation is not solely due to numerical loss of these cells in circulation.
Sepsis-induced lesion of vascular endothelium contributes to impaired skin CD8 T RM responses
At this point, it was evident that recruitment of effector cells to the skin of septic hosts was greatly reduced-an observation that could not be exclusively attributed to impairments in Effect of polymicrobial sepsis on tissue resident memory CD8 T cells 3 Naïve P14 CD8 T cells (Thy1.1) were adoptively transferred into C57Bl/6 recipient hosts (Thy1.2) followed by VacV-GP 33 infection of the left ear. After 50 days mice underwent CLP or sham surgery. Mice received intravascular injection of CD45.2 mAb 2 days later and three minutes later cells within the left ear were enumerated to determine baseline cellularity. Another group of VacV-immune mice received adoptive transfer of 14 × 10 6 CFSE-labeled splenocytes from LCMV-immune donor mice and intradermal injection of 50μg of GP [33] [34] [35] [36] [37] [38] [39] [40] [41] peptide in the left ear performed to activate GP 33 -specific skin T RM . Mice received intravascular injection of CD45.2 mAb 2 days later. Tissues of interest were harvested 3 minutes later and analyzed. (B) Representative gating of CFSE skin T RM Ag-dependent function to produce IFN-γ, the numerical loss of circulating cells that could be recruited to the inflamed peripheral site, or T cell intrinsic factor(s) that might prevent T cells exposed to sepsis or post-septic environment to follow inflammatory cues. Therefore, we focused on the contribution of T cell-extrinsic factors for the observed lesion in T RMmediated responses.
Decoration of the vascular endothelium with chemokines and adhesion molecules permits entry of other recirculating lymphocyte lineages into the site of T RM activation [18] . As administration of exogenous IFN-γ into barrier tissues can recapitulate T RM -anamnestic responses (e.g., vascular endothelium upregulation of adhesion molecules and chemokines that promote bystander activation), we first examined the extent to which sepsis affects the capacity of vascular endothelial cells to respond to exogenous IFN-γ [18] . Naïve mice underwent CLP or sham surgery and 2 days later received IFN-γ or PBS in left and right ears, respectively, by i.d. injection (Fig 6A) . While vascular endothelial cells (CD45.2-CD31+) from sham-treated mice had increased expression of CXCL9 and VCAM-1 after IFN-γ stimulation compared to endothelial cells in the contralateral ear exposed to PBS, we noted a significant reduction in CXCL9 and VCAM-1 expression on vascular endothelial cells from similarly treated mice post CLP (Fig  6B-6D) . One potential explanation for this reduced CXCL9 and VCAM-1 expression on vascular endothelial cells in the post-septic environment was reduced expression of IFN-γR1 ( Fig  6E) . Importantly, the reduced IFN-γR1 expression on the endothelial cells was observed in both left and right ears suggesting a systemic change in skin vascular endothelium receptor expression during the immunoparalysis phase of sepsis (Fig 6F-6I) .
To examine potential mechanisms driving the reduced IFN-γR1 expression on vascular endothelial cells early after sepsis induction new groups of sham and CLP mice were generated and the kinetics of IFN-γ secretion in the plasma were determined during the first 72 hours post-surgery (S8A Fig). CLP induces rapid and transient IFN-γ production (S8B Fig) suggesting that sepsis-induced IFN-γ during cytokine storm might lead to downregulation of IFN-γR1 expression as previously defined [42, 43] . To test this, IFN-γ sufficient (wild type) and IFN-γ-deficient (GKO) mice underwent sham or CLP surgery and the expression of IFN-γR1 on CD31+ CD45.2-ear and heart endothelial cells assessed (Fig 6J) . Importantly, sepsisinduced downregulation of IFN-γR1 on endothelial cells was not observed (Fig 6K-6P ) in GKO mice strongly suggesting the contribution of sepsis-induced IFN-γ in IFN-γR1 downregulation.
We continued our analysis of the effect of sepsis on vascular endothelial cells by evaluating their responsiveness to T RM -derived IFN-γ, which more accurately models an infection situation. T RM (both total and Ag-specific P14 CD8 T cells) were significantly increased in the left ear (primary site of VacV-GP 33 -infection) compared to the uninfected contralateral right ear 30 days after infection (Fig 7B) [22, 34] . This allowed us to determine the impact of T RMderived IFN-γ in left and right ears by comparing the expression of endothelial cell-derived factors that promote bystander immune cell recruitment. VacV-GP 33 Effect of polymicrobial sepsis on tissue resident memory CD8 T cells (Fig 7A-model) . In agreement with data presented before, sepsis did not affect the fold change in gene expression of T RM effector cytokines, IFN-γ and IL-2, in the left ear (Fig 7D and 7E) . The observed fold change increase was more evident in the left ear-a site where skin T RM were present at a much higher number than the contralateral right ear. There was, though, a substantial reduction in mRNA expression of the CXCR3 ligands CXCL9 and CXCL10 in the left ear, which likely contribute to the reduction in T RM -mediated bystander immune cell recruitment in CLP-treated mice (Fig 7F and 7G ) [18, 19] . These data suggest the possibility that sepsis leads to sub-optimal production of CXCR3 ligands that facilitate bystander effector cells recruitment upon skin T RM activation despite sufficient IFN-γ production from skin T RM . In a subsequent experiment, we confirmed the qRT-PCR data by examining the expression of CXCL9 and VCAM-1 protein on the vascular endothelium after skin T RM activation. Upregulation of these molecules on endothelial cells was primarily relegated to the site of VacV infection (Fig 7H-7K) , but was significantly reduced in the CLP-treated mice. Finally, examining this process topologically using immunofluorescence we confirmed that CXCL9 co-localization of CD31+ vascular endothelium of the ear is diminished in the septic host upon T RM activation (Fig 7L and 7M ). Lastly, we tested the ability of endothelial cells to respond to T RM -derived IFN-γ after homologous VacV-GP 33 Exogenous CXCL9/10 administration at time of skin T RM activation improves effector cell recruitment in septic hosts
To address the exciting possibility that exogenous administration of CXCR3 chemokines are sufficient to improve effector cell recruitment to the site of T RM activation VacV-GP 33 -immune P14 chimera mice received CLP surgery 2 days before intradermal injection of GP 33 peptide in the presence or absence of CXCL9/10 chemokines (Fig 8A) . Dramatic increase in ear thickness and number of cells (total and/or effector T and B cell populations) was observed in the ear of CLP mice that received CXCR3 chemokines (Fig 8B-8F) . We next visualized the T RM -mediated recruitment of effector cells into the periphery by adoptively transferring naïve P14-RFP TCR-Tg CD8 T cells into congenic B6 mice before VacV-GP 33 infection of the ear. At memory time point surgery was performed and 2 days later sham and CLP mice received 3 naïve P14 CD8 T cells (Thy1.1) were adoptively transferred into C57Bl/6 recipient hosts (Thy1.2) followed by VacV-GP 33 infection of the left ear. After 40 days mice underwent CLP or sham surgery. One group of mice received intradermal injection of 50μg of GP 33 while second group of mice were injected with 50μg OVA 257 peptide in both ears (left ear-primary and right adoptive transfer of CTV-labelled splenocytes obtained from Listeria monocytogenes immune donors (Fig 8G) . Immediately after the transfer, ears containing P14-RFP memory cells were injected with GP 33 peptide in the presence or absence of CXCL9/10 chemokines and the number of RFP+ or CTV+ cells visualized with 2-photon intravital microscopy 2 days later ( Fig  8G) . Corroborating data shown previously, the calculated number of RFP+ P14 cells per microscopy field of the ear was not different between sham and CLP mice (10.5 +/-3.7 vs 11.1 +/-2.5, respectively). However, sepsis prevented efficient recruitment of CTV+ cells upon T RM peptide activation that was restored after exogenous CXCL9/10 administration (Fig 8H and  8I) suggesting a potential way to correct sepsis-induced impairments in effector cell recruitment to the site of localized infection/inflammation.
Sepsis diminishes protection against localized VacV re-challenge
Due to the critical interplay between T RM and T CIRCM in providing optimal protection upon pathogen re-encounter we next examined the impact of sepsis on the T RM -mediated protection after VacV-GP 33 re-challenge. However, the capacity of memory CD8 T cells to provide protection is always addressed in comparison to naïve, non-immunized host. The fact that sepsis increases susceptibility of naïve host to various types of bacterial or viral infections [8, 9, 11, 44] could complicate the interpretation of the results in which the contribution of T RM cell-mediated protection is determined. To precisely define the time after VacV-infection when viral load in the infected ear is not markedly influenced by sepsis, naïve mice underwent sham or CLP surgery 2 days before VacV infection of the left ear (Fig 9A) . Although sepsis clearly increased susceptibility to VacV infection similar viral load is observed 2 days post infection in CLP and sham hosts (Fig 9B) giving us the opportunity to use this model to address the role of sepsis in shaping T RM cell-mediated protection.
Naïve mice were infected in the left ear to generate T RM at the site of primary infection. Infected and naïve groups of mice were challenged with VacV-GP 33 in left and right ears 2 days after sham or CLP surgery (Fig 9C) . Two days after infection, naïve hosts showed high viral burden with no appreciable difference in viral titers after sepsis induction (Fig 9D) , just as determined in Fig 9A and 9B . Interestingly, viral burden was~38-fold higher in the left ears of CLP-compared to sham-treated immune mice strongly suggesting that sepsis has the capacity to impair T RM cell-mediated protection to localized virus re-challenge (Fig 9D) .
To confirm the contribution of T RM in homologous anti-VacV protection that was not dependent on the other arms of adaptive immunity (e.g. anti-VacV antibodies generated after vaccination) viral burden was also examined in right ears that had similar contributions of anti-VacV immune responses from the periphery except significantly reduced numbers of local T RM . Importantly, viral clearance was reduced in the contralateral ears (compared to the left ears) in vaccinated sham hosts, suggesting the number of skin T RM indeed influences viral clearance upon homologous VacV infection [22, 24] . However, there was only a 3-fold increase in viral burden in the contralateral right ears of vaccinated CLP-treated mice, suggesting the sepsis influence on non T RM -mediated arms of immunity is less pronounced (Fig 9D) . Finally, septic hosts had similar viral burden in both ears despite dramatically different number of skin T RM strongly suggesting CD8 T RM function is diminished upon sepsis induction. Thus, sepsis reduces protection against VacV re-challenge by preventing efficient recognition of T RMdependent 'alarming' signals at the site of localized infection.
Discussion
Sepsis is a robust immune response against a systemic infection that can lead to widespread host tissue damage or death [45] . The early phase of sepsis is characterized by a cytokine storm resulting from the production of a variety of pro-and anti-inflammatory cytokines that contribute to the pathophysiological responses leading to early death of septic patients [46] . After resolution of the cytokine storm, the host enters a period of immunosuppression hallmarked by robust lymphocyte apoptosis and enhanced susceptibility to secondary infections and latent viral reactivation (e.g., HSV) [6, 47] . We and others have used the CLP model of sepsis because of its similarities to clinical manifestations of sepsis [48] , and we have previously described how CLP-induced sepsis reduces the quantity and quality of naïve and memory CD4 and CD8 T cells [8, 9, 12, 15, 49] . Moreover, we recently detailed how the consequences of sepsis on the number and function of dendritic cells contribute to the observed impairments in primary T cell responses [14] . Thus, it is likely that intrinsic and extrinsic lesions contribute to the suboptimal T cell-dependent responses in septic hosts [15] .
The ability to develop and sustain memory CD8 T cells after immunization or infection is a hallmark of the adaptive immune response and a basis for protective vaccination against infectious disease. Memory CD8 T cells possess several important features that distinguish them from naïve CD8 T cells. They are increased in numbers providing better coverage and a more rapid response during pathogen re-encounter. Memory CD8 T cells have experienced cellintrinsic "programming" changes that allow for rapid expression of effector cytokines, chemokines, and cytotoxic molecules. Finally, and most relevant to the work described herein, memory CD8 T cells can establish residence in both lymphoid (T CIRCM ) and non-lymphoid tissues (T RM ). By taking advantage of a simple in vivo labeling procedure, various quantitative and qualitative parameters of CD8 T CIRCM and T RM can be interrogated. Although CD8 T cells that are i.v.-negative are broadly considered CD8 T RM , some memory CD8 T cells could have transient residence within previously infected tissues. Thus, in addition to CD103 expression, parabiosis could be used to rigorously define 'true' tissue residence in the i.v.-negative CD8 T cell compartment.
The evaluation of both CD8 T CIRCM and T RM cell populations from the same mice allowed us to confirm previously reported sepsis-induced alterations in CD8 T CIRCM cells while extending our investigation to include the understudied CD8 T RM population. Sepsis-induced impairments in the number and Ag-dependent functions were evident in "i.v.-positive" Effect of polymicrobial sepsis on tissue resident memory CD8 T cells T CIRCM to a greater extent than "i.v.-negative" CD103+ T RM counterparts in multiple barrier tissues. Interestingly, one report observed a numerical loss of memory CD8 T cells in the blood and SLO (spleen) but no numerical changes were noted in nonlymphoid tissues, including the lungs [50] . An important limitation of this previous report was the absence of intravascular staining to distinguish between Ag-specific memory CD8 T cells in circulation and tissue parenchyma [31, 32] . While it remains unclear which factors are responsible for the numerical and functional maintenance of T RM in septic hosts, we can posit a few explanations. CD8 T RM are phenotypically distinct from their T CIRCM counterparts, which could potentially alter the susceptibility of these populations to the various factors driving sepsis-induced lymphopenia [16] . Additionally, the local environment in which CD8 T RM and T CIRCM reside may vary widely during the hyperinflammatory phase of sepsis. It stands to reason that T CIRCM located in blood and SLO may have greater exposure to pro-and anti-inflammatory cytokines produced during the cytokine storm than cells separated from the circulation within the parenchyma of barrier tissues, leading to the differences in sepsis-induced numerical loss.
Another important question to be answered is how CD8 T RM in various barrier tissues are numerically and/or functionally altered long after the initial septic event. While we observed similar numbers of CD8 T RM in all barrier tissues examined (skin, lung, and gut), it is possible that the long-term numerical maintenance of CD8 T RM after sepsis induction depends on the tissue of residence. For example, skin CD8 T RM are numerically stable over time, suggesting this population might maintain optimal numbers long-term because sepsis does not initially impair the number of CD8 T RM . In contrast, evidence exists that lung CD8 T RM do not maintain themselves numerically and require constant replacement and seeding of the lung with their Ag-specific T CIRCM counterparts. It is believed this is required because of the high rate of homeostatic turnover of lung CD8 T RM , which we also report here [51, 52] . Thus, our 'snapshot' analysis of lung CD8 T RM may not accurately reflect the long-term consequences of sepsis on this population. It is important to reiterate that barrier tissues have vastly different local environments and while we show similarity between all examined tissues we acknowledge it is possible CD8 T RM throughout the body may not behave identically after sepsis induction [53] . Future experiments will be designed to address this important question.
Vascular endothelial cell dysfunction has been widely described in sepsis and results in low blood pressure in septic patients [54] . Early after sepsis induction, the vascular endothelium responds to the cytokine storm by increasing expression of adhesion molecules (e.g. VCAM-1) to promote interaction with innate immune cells which produce factors, including oxygen radicals and elastase, that lead to dysfunction or death of vascular endothelium [55, 56, 57, 58] . Interestingly, the production of compounds that affect the normal function of the vascular endothelium correlate with outcome during sepsis [59, 60, 61] . Therefore, it stands to reason the degree of vascular endothelium dysfunction might be altered based on sepsis severity. Our observed impairments of vascular endothelium to respond to T RM -derived IFN-γ suggest an additional T cell extrinsic factor contributing to sub-optimal memory CD8 T cell responses in septic hosts [15] . This finding is important given recent therapeutic strategies meant to restore number and/or function of memory CD8 T cells in septic patients, including cytokine therapy (IL-7 or IL-15) and checkpoint blockade (anti-PD-L1) [10, 62, 63] . This report further supports the notion that merely focusing on fixing T cell impairments after sepsis induction may not fully restore CD8 T cell-mediated responses [14, 15] .
In summary, we showed that sepsis had minimal impact on number and Ag-dependent 'sensing' and 'alarming' function of CD8 T RM in a variety of barrier tissues. However, the ability of skin T RM to recruit other circulating immune effector cells to the site of skin T RM activation after local Ag deposit or homologous infection was significantly decreased in septic hosts. We determined IFN-γ produced shortly after sepsis induction altered IFN-γR1 expression and function of vascular endothelium leading to impairments in VCAM-1 and CXCL9 expression upon exposure to exogenous or T RM -derived IFN-γ. Importantly, recombinant CXCL9 and CXCL10 application at the site of T RM activation was sufficient to restore the described lesion in effector cell recruitment to the skin. Chemokine therapy in animal models has proven beneficial in promoting protective immune responses in situations where normal host immune responses are insufficient to mediate protection. Specifically, chemokine therapy has been used in tissue-specific immunization strategies against HSV2 [64] and recruiting anti-tumor immune responses to the site of tumor development [65, 66] . Thus, this finding suggests CXCL9 and CXCL10 administration at the site of secondary skin infections could improve the localized immune responses of septic patients as a supplement to conventional antibiotic interventions. These data also build on our previous findings to suggest sepsis-induced suppression of memory CD8 T cell immunity is due to both T cell-intrinsic and -extrinsic lesions, which together contribute to the increased susceptibility of sepsis survivors to previously-encountered infections.
Materials and methods

Ethics statement
Experimental procedures using mice were approved by University of Iowa Animal Care and Use Committee under ACURF protocol numbers 1312217 and 6121915. The experiments performed followed Office of Laboratory Animal Welfare guidelines and PHS Policy on Humane Care and Use of Laboratory Animals.
Mice, pathogens and memory CD8 T cell generation
Inbred C57Bl/6 (B6; Thy1.2/1.2) and outbred Swiss Webster mice were purchased from the National Cancer Institute (Frederick, MD) and maintained in the animal facilities at the University of Iowa at the appropriate biosafety level. IFN-γ knockout (GKO) mice and P14 T cell receptor-transgenic (TCR-Tg) mice (Thy1.1/1.1) were bred and maintained at the University of Iowa (Iowa City, IA). B6.CAG.MRFP1-mice were obtained from Jackson labs and crossed with B6.P14-Thy1.1 mice at the University of Iowa to yield RFP-P14 Thy1.1 B6 mice. LCMVArmstrong (2x10 5 PFU) was injected i.p. Recombinant ActA-deficient Listeria monocytogenes expressing OVA (LM-OVA) was injected i.v. (1x10 7 ). For influenza infection, mice were anesthetized with isoflurane and recombinant PR8-GP 33 (4x10 4 TCID50 provided by Dr. Steven
Varga, University of Iowa) was administered i.n. VacV-GP 33 or VacV WR infection of the skin was performed by applying 5x10 6 PFU in 5 μl saline to the center of the ear pinna and then poking it 30 times with a 27-gauge needle [34] . VacV-GP 33 viral titers were quantified using plaque assay on BSC-40 cells, as described previously [67] . 5-10x10 3 naïve P14 cells obtained from peripheral blood of naïve P14 mice (Thy1.1) were adoptively transferred into B6 recipients (Thy1.2) i.v., followed by infection with a pathogen expressing the GP 33-41 epitope of LCMV.
Cell isolation
Peripheral blood (PBL) was collected by retro-orbital bleeding. Ears, small intestine, and lungs were treated with collagenase type II (Worthington, 100 U/mL) in RPMI 1640 supplemented with 5% fetal calf serum (FCS) and shaken at 450 RPM for 30-90 min at 37˚C. Single cell suspension was prepared by mashing tissues through a 70 μm cell strainer (Falcon) with the plunger of a 1 mL syringe (BD Biosciences). Samples were centrifuged and re-suspended in RPMI. Single-cell suspensions from spleen, lymph nodes and heart were generated after mashing tissue through 70 μm cell strainer without enzymatic digestion.
Flow cytometry, peptides and cytokine detection
Flow cytometry data were acquired on a FACSCanto (BD Biosciences, San Diego, CA) and analyzed with FlowJo software (Tree Star, Ashland, OR). To determine expression of cell surface proteins, mAb were incubated at 4˚C for 20-30 min and cells were fixed using Cytofix/ Cytoperm Solution (BD Biosciences) and, in some instances followed by mAb incubation to detect intracellular proteins. The following mAb clones were used: CD8 (53-6.7; eBioscience), Thy1.1 (HIS51; eBioscience), B220 (RA3-6B2; eBioscience), CD45. . IFN-γ receptor was detected using CD119-Biotin (2E2; eBioscience) and Streptavidin-PE (eBioscience) after acid stripping, as described previously [68] . Plasma concentrations of IFN-γ were determined using Multiplex Immunoassay (ProcartaPlex; Affymetrix by eBioscience) on a Bio-Rad BioPlex, as performed previously [69] . Intravascular stain protocol to distinguish circulatory from resident cells: two minutes after APC-conjugated CD45.2 mAb was injected i.v. into mice, peripheral blood was collected by retro-orbital bleeding and used as a positive control with >99% memory P14 cells routinely labeled with CD45.2 mAb [32] . After an additional minute, mice were euthanized and organs of interest were harvested and processed for flow cytometry.
Intracellular cytokine staining: for in vitro bystander responses, splenocytes were incubated for 4 hours at 37˚C with recombinant IL-12 and IL-18, or IL-12 and TNF, or IL-18 and IFN-β (10 ng/mL each) (R&D Systems). Cells were incubated for 1 additional hour in the presence of Brefeldin A (BFA) before surface and intracellular IFNγ staining. For Ag-dependent CD8 T cell responses splenocytes were incubated with 200nM GP [33] [34] [35] [36] [37] [38] [39] [40] [41] peptide at 37˚C for 5 hours in the presence of BFA before surface and intracellular cytokine staining as described [70] .
GP [33] [34] [35] [36] [37] [38] [39] [40] [41] (KAVYNFATM) and OVA 257-264 (SIINFEKL) peptides were synthesized by BioSynthesis (Louisville, TX).
Apoptosis was evaluated using Vybrant FAM Caspase-3/7 Assay Kit (Invitrogen) according to manufacturer's protocol.
In vivo peptide stimulation of skin T RM and CXCL9/10 administration Skin T RM in VacV-immunized hosts were activated in situ with 50μg transdermal injection of indicated peptides at the immunization site as described [34] . Single cells suspension from the ears is obtained 6 hours later and stained for surface and intracellular antigens/cytokines in the absence of BFA. When stated, 3μg of CXCL9 and CXCL10 (Peprotech) was added to the site of peptide injection as previously described [64] .
Memory CD8 T cell migration assay
LCMV-immune mice splenocytes were resuspended in migration medium (5x10 6 cells per mL of 0.1% FCS supplemented 1xHBSS) and plated in 96 well transwell plate with polystyrene membrane and 5μm pores (Corning) as described [40] . Transwell insert was removed and migration medium supplemented with 1,000ng/mL of CXCL9 or CXCL10 (Peprotech) added to receiving plate. With transwell insert returned to receiving plate 100 μl of splenocytes suspension was added to transwell and incubated for 90 minutes at 37˚C. Migrated cells were collected in the receiving plate and stained as described previously. P14 and Ag-experienced (CD8α   lo   CD11a hi ) CD8 T cell populations were enumerated using flow cytometric 'Count' in the receiving plate using FlowJo software.
CFSE and CTV cell labeling
Splenocytes (10 7 /mL) from LCMV-immune mice were labeled with CarboxyFluorescein diacetate Succinimidyl Ester (CFSE; eBioscience) by incubating the cells at room temperature for 15 minutes with 5μM CFSE. The labeled cells were incubated for 5 minutes with 1mL FCS on ice to remove any free CFSE, and washed three times with RPMI 1640 supplemented with 10% FCS prior to adoptive transfer by i.v. injection, as we performed previously [70] .
Splenocytes isolated from LM-OVA immune mice were labeled with CellTrace Violet (CTV, Life Technologies) by incubating the cells at 37˚C for 20 minutes with 10mM CTV. The labeled cells were then incubated for 5 minutes with 1mL FCS on ice to remove any free CTV, and washed three times with RPMI 1640 supplemented with 10% FCS prior to adoptive transfer by i.v. injection, as performed previously [71] .
Ear thickness
An electronic digital micrometer (Marathon) 0-1" range was placed on the center of the ear pinna to record thickness, as reported previously [34] .
Quantitative RT-PCR
Total RNA was reverse-transcribed using a QuantiTech Reverse Transcription Kit (Qiagen). The resulting cDNA was analyzed for expression of different genes by quantitative PCR using SYBR Advantage qPCR pre-mix (Clontech) on an ABI 7300 Real Time PCR System (Applied Biosystems). Relative gene expression levels in each sample were normalized to beta-actin (ACTB). Primers used in quantitative RT-PCR were: IFN-γ: forward-GCGTCATTGAATCACACCTG and reverse-TGAGCTCATTGAATGCT TGG; IL-2: forward-AACCTGAAACTCCCCAGGAT and reverse-CGCAGAGGTCCAAG TTCATC; CXCL9: forward-TCGGACTTCACTCCAACACAG and reverse-AGGGTTCCT CGAACTCCACA; CXCL10: forward-CCACGTGTTGAGATCATTGCC and reverse-GAGG CTCTCTGCTGTCCATC; and ACTB: forward-CGGTTCCGATGCCCTGAGGCTCTT and reverse-CGTCACACTTCATGATGGAATTGA.
Cecal ligation and puncture (CLP) model of sepsis induction
Mice were anesthetized with ketamine/xylazine (University of Iowa, Office of Animal Resources), the abdomen was shaved and disinfected with Betadine (Purdue Products), and a midline incision was made. The distal third of the cecum was ligated with Perma-Hand Silk (Ethicon), punctured once using a 25-gauge needle, and a small amount of fecal matter extruded. The cecum was returned to abdomen, the peritoneum was closed with 641G PermaHand Silk (Ethicon), and skin sealed using surgical Vetbond (3M). Following surgery, 1 mL PBS was administered s.c. to provide post-surgery fluid resuscitation. Bupivacaine (Hospira) was administered at the incision site, and flunixin meglumine (Phoenix) was administered for postoperative analgesia. This procedure created a septic state characterized by loss of appetite and body weight, ruffled hair, shivering, diarrhea, and/or periorbital exudates with 0-10% mortality rate, similar to our previous reports [8, 9, 12, 14] . Sham mice underwent identical surgery excluding cecal ligation and puncture. 
Whole epidermal mounts immunofluorescence and confocal microscopy
VacV-GP 33 immune mice underwent sham or CLP surgery. Whole epidermal ear mounts were processed from isolated ears, as described [72] . Briefly, ears from non-stimulated or GP 33 -peptide stimulated sham or CLP mice were collected 24 hours after stimulation, treated with Nair (Church and Dwight Co.) for 5 minutes to remove hair, affixed to slides with super glue and incubated in 10mM EDTA in PBS for 2 hours at 37˚C. The dermis was physically removed from the epidermis and the epidermal sheets were fixed in 4% paraformaldehyde for 2 hours at 4˚C. Tissues were rinsed in TBS and blocked with CAS-Block (Life Science Technologies) and stained with CD3-Alexa594, CD31-Alexa488, and CXCL9-Alexa647 (Biolegend) at 4˚C for 12-16 hrs. Sections were rinsed in TBS and mounted on slides with ProLongGold (Invitrogen). Images were acquired with sequential imaging with excitation of 488nm and emission 500-550nm for Alexa488, excitation at 561 and emission at 600-650 for Alexa594 and excitation at 633 and emission at 650-720nm for Alexa647. Sequences of image stacks were transformed into volume-rendered, 3D images with Imaris Version 8.4 (Bitplane).
Statistical analysis
Unless stated otherwise data were analyzed using Prism6 software (GraphPad) using twotailed Student t-test with a confidence interval of >95% to determine significance ( Ã p 0.05, ÃÃ p 0.01, ÃÃÃ p 0.001, ÃÃÃÃ p 0.0001 and N.S. as not significant) data are presented as standard error of the mean. 
